/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

OSR Holdings Incs Share Price Today: Live Updates & Key Insights

OSR Holdings Incs share price today is $0.5, up 5.29%. The stock opened at $0.4908 against the previous close of $0.4749, with an intraday high of $0.535 and low of $0.475.

OSR Holdings Incs Share Price Chart

style
pb-0

OSR Holdings Incs

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

OSR Holdings Incs Share Price Performance

$0.5 0.0529(5.29%) OSRH at 13 Mar 2026 02:38 PM Biotechnology
Lowest Today 0.475
Highest Today 0.535
Today’s Open 0.4908
Prev. Close 0.4749
52 Week High 4.33
52 Week Low 0.38
Day’s Range: Low 0.475 High 0.535
52-Week Range: Low 0.38 High 4.33
1 day return -
1 Week return +0.15
1 month return +6.8
3 month return -12.07
6 month return -20.54
1 year return -64.81
3 year return -
5 year return -
10 year return -

OSR Holdings Incs Institutional Holdings

OSR Holdings Incs Market Status

OSR Holdings Incs Fundamentals

Market Cap 12.19 M

PB Ratio 0.1566

PE Ratio 0.0

Enterprise Value 14.39 M

Total Assets 2.30 M

Volume 410223

OSR Holdings Incs Company Financials

About OSR Holdings Incs & investment objective

Company Information OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.

Organisation Biotechnology

Employees 19

Industry Biotechnology

CEO Mr. Senyon Choe

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow